Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00581321 · ClinicalTrials.gov registry record · NA

Oral Water Ingestion in Heart Transplant Patients

A NA study of Blood Pressure and Cardiac Transplantation, sponsored by Satish R. Raj.

Active
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT00581321: Active NA study of Blood Pressure and Cardiac Transplantation, sponsored by Satish R. Raj.

NCT00581321 is a NA study of Blood Pressure and Cardiac Transplantation that is active but no longer recruiting, run by Satish R. Raj. The registered enrollment target is 40 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00581321, a NA study of Blood Pressure and Cardiac Transplantation, is active but no longer recruiting, sponsored by Satish R. Raj.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

In this study the investigators propose to assess the hemodynamic response to the ingestion of 16 fl oz of water. The investigators will test the hypothesis that water ingestion will increase the systemic vascular resistance.

Primary Outcome

TPR measured by Modelflow

Interventions

  • DIETARY_SUPPLEMENT water

Study Locations (2)

Tennessee

  • Tennessee Valley Health Systems (Nashville VA) - Nashville
  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2006-01
Est. Completion 2029-12
Phase NA
Satish R. Raj

7 total trials

What the registry record for NCT00581321 still lists

NCT00581321 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (86% lower).

The record links to 2 conditions, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which water is the first listed.

NCT00581321 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT00581321 about?

NCT00581321 is a clinical study titled "Oral Water Ingestion in Heart Transplant Patients". In this study the investigators propose to assess the hemodynamic response to the ingestion of 16 fl oz of water. The investigators will test the hypothesis that water ingestion will increase the systemic vascular resistance.

What is the current status of trial NCT00581321?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2006-01. Estimated completion is 2029-12.

What conditions does trial NCT00581321 study?

This clinical trial studies the following conditions: Blood Pressure, Cardiac Transplantation.

What interventions are being tested in trial NCT00581321?

The interventions under investigation include: water (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00581321?

This trial is sponsored by Satish R. Raj, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00581321 being conducted?

This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00581321's enrollment target sits among peer trials

40 67th of 101 higher than 30 of 101 other Blood Pressure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00581321, the US trial registry maintained by the National Library of Medicine. NCT00581321 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.